Skip to main content

Aggressive Systemic Mastocytosis (ASM) clinical trials at UC Cancer

1 research study open to eligible people

Showing trials for
  • (Apex) CGT9486 in Patients With Advanced Systemic Mastocytosis

    open to eligible people ages 18 years and up

    This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).

    at UCLA

Last updated: